AINEWS
Generative videos impersonate real physicians to push unapproved drugs and supplements; a documented method of forging cargo declarations could — if applied to pharmaceuticals — open a route through customs, in a market projected to reach US$1
A deepfake video sells the product. A falsified cargo declaration gets it past the port. Malaysian enforcement, built to chase street peddlers, is reading the wrong paperwork at the wrong speed.
Bernama and the New Straits Times documented the marketing layer in August: AI-generated videos impersonating a real cardiologist, Dr Onn Akbar Ali of KPJ Kajang Specialist Hospital, pushing herbal tea as a diabetes cure. The fake clip promises results "tanpa ubat, tanpa suntikan, tanpa kesan sampingan," Malay for "without medicine, without injection, without side effects," in a doctor's voice he never used. Versions of the same template have been used to sell unapproved supplements and counterfeit prescription drugs through e-commerce platforms, social media, and messaging apps. Sellers rotate accounts the moment a takedown notice lands.
The supply side is what makes the new pattern potentially more dangerous. In February 2026, RDS Law Partners documented authorities intercepting two shipping containers at West Port, Port Klang, holding more than 37 tonnes of illegal electronic waste falsely declared in the Customs Information System as ABS plastic flakes and industrial machinery. The seizure showed a falsifier that could travel: customs paperwork of the kind forged in the e-waste case could, in theory, be applied to other cargo categories. If the same falsifier were moved from e-waste to pharmaceuticals, the AI-doctor marketing layer would have a potential port of entry — though enforcement agencies have not yet confirmed such a link in the pharmaceutical supply chain.
Malaysia's regulator has the numbers. A Ministry of Health written reply to Bernama, covering 2023 through 30 June 2026, records 2,839 raids on unregistered supplements, more than 1.5 million products seized worth roughly RM75 million (about US$16 million at typical 2026 exchange rates), and 93 raids on counterfeit pharmaceutical products covering more than 4,000 units worth about RM85,000 (US$19,000). Those seizures are real, and they target a different opponent. The Pharmacy Enforcement Division's "broken windows" strategy chases small retailers, night-market sellers, and street peddlers, according to a May 2026 analysis by CodeBlue. It is not built to read a forged product code on a 20-foot container.
The legal frame is older than the fraud. Neither the Sale of Drugs Act 1952 nor the Control of Drugs and Cosmetics Regulations 1984 defines "unregistered medicine" or "counterfeit medicine." Prosecutors reach for Section 12 of the 1952 Act, a general penalty provision without mandatory minimums. On the customs side, RDS Law Partners outlines Section 133 of the Customs Act 1967, which sets penalties of up to RM500,000 (about US$111,000) and seven years' imprisonment for false declarations, with additional value-multiplier penalties under Section 135(1)(a). The penalties exist. The drug-law definitions do not. The customs verification runs at human document-checker speed.
The cost lands on three groups. Doctors see their faces push products they never endorsed. Pharmacies absorb the counterfeit-control problem: Rachel Gan of Alive Pharmacy in the Klang Valley has tracked impersonators using her brand online, and BREGO Life Sciences, maker of the legitimate BioNerv supplement, restricts sales to Big Pharmacy, Caring Pharmacy, clinics, and hospitals because the online channel cannot be policed. Patients absorb the bodily risk. A 54-year-old cancer patient, Chan Wai Mun, developed liver inflammation after buying counterfeit BioNerv online. A 30-year-old identified only as Shaz paid RM370 (about US$82) for a meal replacement powder and received avocado powder.
The US Trade Office projects Malaysia's nutritional market to reach US$1 billion by 2030, up from US$600 million in 2022. The market is growing. The verification stack — customs declarations, drug-law definitions, pharmacy credential checks, platform takedowns — was built for a slower, smaller, less synthetic adversary.
The falsifier is straightforward. If the Ministry of Health or the National Pharmaceutical Regulatory Agency can confirm that the cargo-declaration thread is a structural vector for unregistered drugs, the AI-plus-paperwork pipeline becomes a documented enforcement case. Until that statement is on the record, the working assumption — supported by the February Port Klang seizure and the August AI-doctor marketing layer — is that the falsifier used for e-waste could be load-bearing for pharmaceutical fraud. Whether it has been used that way remains unconfirmed.